-The Hindu Business Line Bengaluru: Prospects for wheat exports in the new marketing season are turning bleak on falling global prices even as the country is seen headed for a bumper output this year. The recent fall in Euro against the dollar has made the French wheat cheaper thereby exerting pressure on the global prices. Wheat prices, which hovered around $6.6 a bushel in Chicago during mid December are now down to...

-The Asian Age The sharp and sudden collapse of international prices of crude oil brings significant short-term gains for the Indian economy. However, in the medium and long run, the fall in oil prices has ramifications that are far from positive for this country. The windfall gains that have accrued will provide temporary relief for finance minister Arun Jaitley and will enable him to meet the fiscal deficit target in the...

-The Hindustan Times India is likely to face a cotton glut this year. The surplus, however, will be of little comfort to suicide-prone and highly indebted farmers, who stare at a sharp drop in earnings - prices are already down 14% compared with last year. The crisis has to do with a slowdown in China, which is forecast to slash by half the amount of cotton it will import this year, most...

-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...